News - UF Innovate

Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and...

Six UF Researchers Named 2019 AAAS Fellows

Six researchers from across the University of Florida have been named Fellows of the American Association for the Advancement of Science (AAAS), the world’s largest...

New Pumpkin, Calabaza Breeds Make Headway at UF

Pumpkin’s popularity for holiday decor, healthy snacking and recipes during fall and winter months, has given rise to innovative research led by Geoffrey Meru, an...

Curing Mosquitoes, Eliminating Malaria

A new study authored by UF Emerging Pathogens Institute (EPI) researcher Rhoel Dinglasan, Ph.D., and colleagues, twists the narrative in the fight against malaria by...

Study Helps Hepatitis C Patients, Shows Path for Accelerating Research and Potential for Drug Approvals

In a new kind of real-world study, a “pragmatic” clinical trial, UF researchers found that hepatitis C patients who previously did not respond to oral...

SharpSpring Announces Acquisition of Perfect Audience From Marin Software

UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform for digital marketing agencies, announced it has acquired the digital advertising platform Perfect Audience from...

Exactech Acquires Italian Distributor

UF startup Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, announced that it acquired its independent distribution...

$6 Million Expansion for Gene Therapy Facility Completed at Alachua’s Progress Park

Local and state officials gathered in Alachua to commemorate a $6 million expansion at Progress Park. Representatives of Thermo Fisher Scientific Inc., a global science...

DNAtrix Presents Positive Results From Study at the 2019 SNO Annual Meeting

UF startup DNAtrix, a leader in the development of oncolytic viruses for cancer therapy, presented updated safety and efficacy data from the fully-enrolled Phase 2 CAPTIVE...

Algernon Pharmaceuticals Provides Update on Its Planned Phase II Clinical Trial

UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec Biomedical, a clinical-stage pharmaceutical development company, provided an update to the market on its planned phase...

UF News